Document is current
Any future updates will be listed below
-
Authors
Chai, Yi https://orcid.org/0000-0002-9191-2341
Chu, Rachel Yui Ki
Hu, Yuqi
Lam, Ivan Chun Hang https://orcid.org/0000-0002-5891-3940
Cheng, Franco Wing Tak https://orcid.org/0000-0001-7818-1575
Luo, Hao
Wong, Martin Chi Sang
Chan, Sandra Sau Man
Chan, Esther Wai Yin https://orcid.org/0000-0002-7602-9470
Wong, Ian Chi Kei https://orcid.org/0000-0001-8242-0014
Lai, Francisco Tsz Tsun https://orcid.org/0000-0002-9121-1959
- License Information
-
More Information
Article History
Received: 13 March 2023
Accepted: 18 September 2023
First Online: 26 September 2023
Competing interests
: E.C. reports grants from Research Grants Council of Hong Kong, Research Fund Secretariat of the Food and Health Bureau of Hong Kong, National Natural Science Fund of China, Wellcome Trust, Bayer, Bristol-Myers Squibb, Pfizer, Janssen, Amgen, Takeda, and Narcotics Division of the Security Bureau of Hong Kong; honorarium from Hospital Authority; outside the submitted work. I.W. receives research funding outside the submitted work from Amgen, Bristol-Myers Squibb, Pfizer, Janssen, Bayer, GSK, Novartis, the Hong Kong Research Grants Council, the Food and Health Bureau of the Government of the Hong Kong Special Administrative Region, National Institute for Health Research in England, European Commission, and the National Health and Medical Research Council in Australia; has received speaker fees from Janssen and Medice in the previous 3 years; and is an independent non-executive director of Jacobson Medical in Hong Kong. F.L. has been supported by the RGC Postdoctoral Fellowship under the Hong Kong Research Grants Council and has received research grants from the Food and Health Bureau of the Government of the Hong Kong Special Administrative Region, outside the submitted work. The remaining authors declare no competing interests.
